Combined drug therapy may delay melanoma progression
Combination therapy with two drugs delayed the development of treatment resistance in patients with metastatic melanoma that expresses a specific mutation in the BRAF gene. Read More
bar
Myelosuppression unit set to move to new CCT space
New space on the 10th floor of the Critical Care Tower is allowing the myelosuppression unit to increase its number of available… Read More
Grant renewal boosts GI cancer research program
Vanderbilt-Ingram Cancer Center’s gastrointestinal Specialized Program of Research Excellence (SPORE) has been awarded its third round of funding by the National Cancer Institute (NCI). Read More
Carmaker’s gift boosts childhood cancer research
Patrick Grohar, M.D., Ph.D., was awarded a $250,000 Hyundai Hope on Wheels grant last week for his research into potential drug therapies for Ewing sarcoma, a cancer of the bone. Read More
Stand Up to Cancer TV broadcast airs Sept. 7
Stand Up To Cancer (SU2C), the nonprofit organization that helps fund various Vanderbilt-Ingram Cancer Center (VICC) investigators, returns to prime time television… Read More
VICC debuts outpatient cancer clinic in Springfield
Vanderbilt-Ingram Cancer Center (VICC) has opened a new outpatient cancer clinic on the NorthCrest Medical Center campus in Springfield, Tenn., to bring high quality care to patients in Middle Tennessee and Southern Kentucky. Read More
Predators jump in to help fight childhood cancer
The Nashville Predators organization presented more than $151,000 to the Monroe Carell Jr. Children’s Hospital at Vanderbilt recently to fund cutting-edge cancer research. Read More
Study finds mutation in melanoma sensitive to drug
An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation. Read More
New cancer drug shows promise in early testing
An experimental drug that activates T-cells and promotes an immune response to fight tumors has shown promising early results in patients with kidney cancer, melanoma… Read More
Risk of secondary tumors from melanoma drug studied
A new study offers clues on why melanoma patients who are treated with oral drugs inhibiting the BRAF gene are at increased risk for developing secondary skin cancers. Read More
New melanoma drug nearly doubles survival in majority of patients
Investigators from Vanderbilt-Ingram Cancer Center and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival. Read More
Investigators seek clues to resistance to melanoma drug
Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug. Read More
Flexner recalled for compassion, devotion
The halls of VUMC are a little quieter today. John M. Flexner, M.D., professor of Medicine, emeritus, whose booming voice and outgoing personality were a… Read More
Sosman named to ‘Dream Team’ of cancer investigators
Jeffrey Sosman, M.D., professor of Medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of cancer investigators supported by… Read More
Johnson named VUMC Biomedical Informatics chair
Kevin Johnson, M.D., M.S., professor and vice chair of the Department of Biomedical Informatics (DBMI) and professor of Pediatrics, has been named the department’s new… Read More
Jeffrey Sosman named to melanoma research ‘Dream Team’
Jeffrey Sosman (Vanderbilt) Jeffrey Sosman, professor of medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of… Read More
Averting a future oncologist shortage
Providing increased mentorship, research opportunities and a nurturing, intellectual environment during fellowship training may help reduce a projected shortage of academic hematologists and oncologists. Read More
Kudos
Tracy Barrett (Vanderbilt) Tracy Barrett, senior lecturer in Italian, has written Dark… Read More
Eve of Janus set for July 30
The 41st Eve of Janus is scheduled for July 30 at the Schermerhorn Symphony Center in downtown Nashville. Read More
Vanderbilt: Laboratory for health care reform
Vanderbilt University Medical Center is a laboratory for health care reform. Increasingly, Vanderbilt researchers are applying their expertise in informatics, genomics, drug discovery, basic science… Read More
